G Arguello, E Balboa, M Arrese, S Zanlungo - Biochimica et Biophysica …, 2015 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of hepatic histopathological changes ranging from non-inflammatory intracellular fat deposition to non …
U Ozcan, Q Cao, E Yilmaz, AH Lee, NN Iwakoshi… - Science, 2004 - science.org
Obesity contributes to the development of type 2 diabetes, but the underlying mechanisms are poorly understood. Using cell culture and mouse models, we show that obesity causes …
Z Liu, Y Lv, N Zhao, G Guan, J Wang - Cell death & disease, 2015 - nature.com
Over the past few decades, understandings and evidences concerning the role of endoplasmic reticulum (ER) stress in deciding the cell fate have been constantly growing …
A Ajoolabady, C Lebeaupin, NN Wu… - Medicinal research …, 2023 - Wiley Online Library
The endoplasmic reticulum (ER) governs the proper folding of polypeptides and proteins through various chaperones and enzymes residing within the ER organelle. Perturbation in …
F Trettel, D Rigamonti, P Hilditch-Maguire… - Human molecular …, 2000 - academic.oup.com
Lengthening a glutamine tract in huntingtin confers a dominant attribute that initiates degeneration of striatal neurons in Huntington's disease (HD). To identify pathways that are …
Ageing is driven by the inexorable and stochastic accumulation of damage in biomolecules vital for proper cellular function. Although this process is fundamentally haphazard and …
DK Ingawale, SK Mandlik, SR Naik - Environmental toxicology and …, 2014 - Elsevier
Liver is a primary organ involved in biotransformation of food and drugs. Hepatic diseases are a major worldwide problem. Hepatic disorders are mainly caused by toxic chemicals …
Endoplasmic reticulum (ER) stress is a general term for representing the pathway by which various stimuli affect ER functions. ER stress induces the evolutionarily conserved signaling …
O Kepp, L Menger, E Vacchelli, C Locher… - Cytokine & growth factor …, 2013 - Elsevier
Preclinical and clinical findings suggest that tumor-specific immune responses may be responsible–at least in part–for the clinical success of therapeutic regimens that rely on …